T 1590/15 (Efavirenz/ MSD) of 25.10.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T159015.20181025
- Date of decision
- 25 October 2018
- Case number
- T 1590/15
- Online on
- 29 November 2018
- Petition for review of
- -
- Application number
- 03076054.0
- IPC class
- A61K /20A61K /28A61K 1/535
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Efavirenz compressed tablet formulation
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- Sölch, Günter
Generics [UK] Limited (trading as Mylan) - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.